C Rad (Sweden) Performance
| CRAD-B Stock | SEK 30.25 1.30 4.49% |
The firm shows a Beta (market volatility) of 0.58, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, C Rad's returns are expected to increase less than the market. However, during the bear market, the loss of holding C Rad is expected to be smaller as well. At this point, C Rad AB has a negative expected return of -0.44%. Please make sure to confirm C Rad's value at risk, skewness, and the relationship between the maximum drawdown and potential upside , to decide if C Rad AB performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days C Rad AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 122.4 M | |
| Total Cashflows From Investing Activities | -11.2 M |
CRAD-B |
C Rad Relative Risk vs. Return Landscape
If you would invest 4,155 in C Rad AB on September 2, 2024 and sell it today you would lose (1,130) from holding C Rad AB or give up 27.2% of portfolio value over 90 days. C Rad AB is generating negative expected returns and assumes 2.7098% volatility on return distribution over the 90 days horizon. Simply put, 24% of stocks are less volatile than CRAD-B, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
C Rad Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for C Rad's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as C Rad AB, and traders can use it to determine the average amount a C Rad's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1628
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CRAD-B |
Estimated Market Risk
| 2.71 actual daily | 24 76% of assets are more volatile |
Expected Return
| -0.44 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average C Rad is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of C Rad by adding C Rad to a well-diversified portfolio.
C Rad Fundamentals Growth
CRAD-B Stock prices reflect investors' perceptions of the future prospects and financial health of C Rad, and C Rad fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CRAD-B Stock performance.
| Return On Equity | 0.0317 | |||
| Return On Asset | 0.0422 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 1.23 B | |||
| Shares Outstanding | 33.8 M | |||
| Price To Earning | 46.24 X | |||
| Price To Book | 5.61 X | |||
| Price To Sales | 4.84 X | |||
| Revenue | 301.3 M | |||
| EBITDA | 28.4 M | |||
| Cash And Equivalents | 26.8 M | |||
| Cash Per Share | 0.87 X | |||
| Total Debt | 4.1 M | |||
| Debt To Equity | 3.20 % | |||
| Book Value Per Share | 7.18 X | |||
| Cash Flow From Operations | 9.7 M | |||
| Earnings Per Share | 0.42 X | |||
| Total Asset | 339.2 M | |||
| Retained Earnings | (166 M) | |||
| Current Asset | 42 M | |||
| Current Liabilities | 22 M | |||
About C Rad Performance
By analyzing C Rad's fundamental ratios, stakeholders can gain valuable insights into C Rad's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if C Rad has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if C Rad has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
C-Rad AB , together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. C-Rad AB was founded in 2004 and is headquartered in Uppsala, Sweden. C RAD operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 54 people.Things to note about C Rad AB performance evaluation
Checking the ongoing alerts about C Rad for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for C Rad AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| C Rad AB generated a negative expected return over the last 90 days | |
| About 52.0% of the company shares are held by company insiders |
- Analyzing C Rad's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether C Rad's stock is overvalued or undervalued compared to its peers.
- Examining C Rad's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating C Rad's management team can have a significant impact on its success or failure. Reviewing the track record and experience of C Rad's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of C Rad's stock. These opinions can provide insight into C Rad's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CRAD-B Stock analysis
When running C Rad's price analysis, check to measure C Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy C Rad is operating at the current time. Most of C Rad's value examination focuses on studying past and present price action to predict the probability of C Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move C Rad's price. Additionally, you may evaluate how the addition of C Rad to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |